These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 9949940

  • 1. [Treatment of adjustment disorder with anxiety: efficacy and tolerance of etifoxine in a double-blind controlled study].
    Servant D, Graziani PL, Moyse D, Parquet PJ.
    Encephale; 1998; 24(6):569-74. PubMed ID: 9949940
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice.
    Nguyen N, Fakra E, Pradel V, Jouve E, Alquier C, Le Guern ME, Micallef J, Blin O.
    Hum Psychopharmacol; 2006 Apr; 21(3):139-49. PubMed ID: 16625522
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.
    Lee ST, Park JH, Kim M.
    Headache; 2005 Sep; 45(8):1004-11. PubMed ID: 16109114
    [Abstract] [Full Text] [Related]

  • 4. Buspirone in the long-term treatment of generalized anxiety disorder.
    Feighner JP.
    J Clin Psychiatry; 1987 Dec; 48 Suppl():3-6. PubMed ID: 3320034
    [Abstract] [Full Text] [Related]

  • 5. Etifoxine versus alprazolam for the treatment of adjustment disorder with anxiety: a randomized controlled trial.
    Stein DJ.
    Adv Ther; 2015 Jan; 32(1):57-68. PubMed ID: 25620535
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE, Franznick DA, Hollander SB, Fava M.
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [Abstract] [Full Text] [Related]

  • 8. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H, Raassina R, Penttinen J, Ahokas A, Jokinen R, Koponen H, Lepola U, Kanerva H, Lehtonen L, Pohjalainen T, Partanen A, Mäki-Ikola O, Rouru J, Deramciclane Dose-Finding Study Group.
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [Abstract] [Full Text] [Related]

  • 9. Interaction of pharmacological and psychological treatments of anxiety.
    Lader MH, Bond AJ.
    Br J Psychiatry Suppl; 1998 Dec; (34):42-8. PubMed ID: 9829016
    [Abstract] [Full Text] [Related]

  • 10. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
    Brady KT, Clary CM.
    Compr Psychiatry; 2003 Dec; 44(5):360-9. PubMed ID: 14505296
    [Abstract] [Full Text] [Related]

  • 11. The association of buspirone and its metabolite 1-pyrimidinylpiperazine in the remission of comorbid anxiety with depressive features and alcohol dependency.
    Tollefson GD, Lancaster SP, Montague-Clouse J.
    Psychopharmacol Bull; 1991 Dec; 27(2):163-70. PubMed ID: 1924664
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
    Rynn M, Russell J, Erickson J, Detke MJ, Ball S, Dinkel J, Rickels K, Raskin J.
    Depress Anxiety; 2008 Dec; 25(3):182-9. PubMed ID: 17311303
    [Abstract] [Full Text] [Related]

  • 13. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV, McElroy SL, Harnett-Sheehan K, Keck PE, Janavs J, Rogers J, Gonzalez R, Shivakumar G, Suppes T.
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms.
    Russell JM, Weisberg R, Fava M, Hartford JT, Erickson JS, D'Souza DN.
    Depress Anxiety; 2008 Jun; 25(7):E1-11. PubMed ID: 17587217
    [Abstract] [Full Text] [Related]

  • 15. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.
    Pollack MH, Tiller J, Xie F, Trivedi MH.
    J Clin Psychopharmacol; 2008 Jun; 28(3):308-16. PubMed ID: 18480688
    [Abstract] [Full Text] [Related]

  • 16. The safety and usefulness of buspirone as an anxiolytic drug in elderly versus young patients.
    Robinson D, Napoliello MJ, Schenk J.
    Clin Ther; 1988 Jun; 10(6):740-6. PubMed ID: 3219687
    [Abstract] [Full Text] [Related]

  • 17. Clorazepate dipotassium in anxiety: a double-blind trial with diazepam controls.
    Wiersum J.
    Curr Ther Res Clin Exp; 1972 Aug; 14(8):442-8. PubMed ID: 4629306
    [No Abstract] [Full Text] [Related]

  • 18. Early response and 8-week treatment outcome in GAD.
    Rynn M, Khalid-Khan S, Garcia-Espana JF, Etemad B, Rickels K.
    Depress Anxiety; 2006 Aug; 23(8):461-5. PubMed ID: 16845651
    [Abstract] [Full Text] [Related]

  • 19. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
    Bose A, Korotzer A, Gommoll C, Li D.
    Depress Anxiety; 2008 Aug; 25(10):854-61. PubMed ID: 18050245
    [Abstract] [Full Text] [Related]

  • 20. Etifoxine is non-inferior than clonazepam for reduction of anxiety symptoms in the treatment of anxiety disorders: a randomized, double blind, non-inferiority trial.
    Vicente B, Saldivia S, Hormazabal N, Bustos C, Rubí P.
    Psychopharmacology (Berl); 2020 Nov; 237(11):3357-3367. PubMed ID: 33009629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.